The Phosphate Company Share Price
Sector: Chemical Manufacturing
146.25 0.00 (0.00%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
146.25
Today’s High
146.25
52 Week Low
134.95
52 Week High
207.90
Key Metrics
- Market Cap (In Cr) 52.76
- Beta -0.31
- Div. Yield (%) 0
- P/B 0.62
- TTM P/E 63.65
- Peg Ratio -8.69
- Sector P/E 17.67
- Open Price 146.25
- Prev Close 146.25
The Phosphate Company Analysis
Price Analysis
-
1 Week-5.34%
-
3 Months-2.95%
-
6 Month4.39%
-
YTD-5.65%
-
1 Year-10.22%
Risk Meter
- 68% Low risk
- 68% Moderate risk
- 68% Balanced Risk
- 68% High risk
- 68% Extreme risk
The Phosphate Company News
Paradeep Phosphates IPO opens for subscription today: 10 things to know
2 min read . 18 May 2022Dolly Khanna portfolio: Ace investor raises stake in this multibagger stock
1 min read . 15 Jan 2022HCL Tech inks five-year strategic partnership with The Mosaic Company
1 min read . 09 Jul 2021The Phosphate Company Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 114.96
- Selling/ General/ Admin Expenses Total
- 4.35
- Depreciation/ Amortization
- 0.99
- Other Operating Expenses Total
- 21.44
- Total Operating Expense
- 108.97
- Operating Income
- 5.99
- Net Income Before Taxes
- 3.11
- Net Income
- 2.01
- Diluted Normalized EPS
- 5.56
- Period
- 2024
- Total Assets
- 120.93
- Total Liabilities
- 36.34
- Total Equity
- 84.59
- Tangible Book Valueper Share Common Eq
- 234.49
- Period
- 2024
- Cashfrom Operating Activities
- 15.64
- Cashfrom Investing Activities
- 5.68
- Cashfrom Financing Activities
- -15.76
- Net Changein Cash
- 5.55
- Period
- 2023
- Total Revenue
- 146.87
- Selling/ General/ Admin Expenses Total
- 4.2
- Depreciation/ Amortization
- 1.03
- Other Operating Expenses Total
- 28.54
- Total Operating Expense
- 138.21
- Operating Income
- 8.67
- Net Income Before Taxes
- 6.55
- Net Income
- 4.7
- Diluted Normalized EPS
- 13.04
- Period
- 2023
- Total Assets
- 141.94
- Total Liabilities
- 59.11
- Total Equity
- 82.83
- Tangible Book Valueper Share Common Eq
- 229.61
- Period
- 2023
- Cashfrom Operating Activities
- -10.57
- Cashfrom Investing Activities
- -4.63
- Cashfrom Financing Activities
- 15.19
- Net Changein Cash
- -0.01
- Period
- 2022
- Total Revenue
- 116.57
- Selling/ General/ Admin Expenses Total
- 3.96
- Depreciation/ Amortization
- 1.05
- Other Operating Expenses Total
- 23.31
- Total Operating Expense
- 109.1
- Operating Income
- 7.47
- Net Income Before Taxes
- 4.29
- Net Income
- 2.75
- Diluted Normalized EPS
- 7.62
- Period
- 2022
- Total Assets
- 111.88
- Total Liabilities
- 33.73
- Total Equity
- 78.14
- Tangible Book Valueper Share Common Eq
- 216.62
- Period
- 2022
- Cashfrom Operating Activities
- 5.85
- Cashfrom Investing Activities
- -2.14
- Cashfrom Financing Activities
- -3.71
- Net Changein Cash
- -0.01
- Period
- 2021
- Total Revenue
- 61.21
- Selling/ General/ Admin Expenses Total
- 3.4
- Depreciation/ Amortization
- 1.05
- Other Operating Expenses Total
- 18.93
- Total Operating Expense
- 54.83
- Operating Income
- 6.38
- Net Income Before Taxes
- 3.5
- Net Income
- 2.49
- Diluted Normalized EPS
- 6.82
- Period
- 2021
- Total Assets
- 108.3
- Total Liabilities
- 32.85
- Total Equity
- 75.45
- Tangible Book Valueper Share Common Eq
- 209.16
- Period
- 2021
- Cashfrom Operating Activities
- 12.07
- Cashfrom Investing Activities
- -0.24
- Cashfrom Financing Activities
- -12.62
- Net Changein Cash
- -0.79
- Period
- 2020
- Total Revenue
- 72.86
- Selling/ General/ Admin Expenses Total
- 3.07
- Depreciation/ Amortization
- 1.06
- Other Operating Expenses Total
- 21.78
- Total Operating Expense
- 66.9
- Operating Income
- 5.96
- Net Income Before Taxes
- 1.98
- Net Income
- 2.12
- Diluted Normalized EPS
- 5.88
- Period
- 2020
- Total Assets
- 115.43
- Total Liabilities
- 42.34
- Total Equity
- 73.09
- Tangible Book Valueper Share Common Eq
- 202.62
- Period
- 2020
- Cashfrom Operating Activities
- 20.03
- Cashfrom Investing Activities
- -1.9
- Cashfrom Financing Activities
- -17.36
- Net Changein Cash
- 0.77
- Period
- 2019
- Total Revenue
- 72
- Selling/ General/ Admin Expenses Total
- 2.88
- Depreciation/ Amortization
- 1.13
- Other Operating Expenses Total
- 17.41
- Total Operating Expense
- 64.43
- Operating Income
- 7.57
- Net Income Before Taxes
- 2.74
- Net Income
- 1.42
- Diluted Normalized EPS
- 3.94
- Period
- 2019
- Total Assets
- 128.68
- Total Liabilities
- 57.61
- Total Equity
- 71.08
- Tangible Book Valueper Share Common Eq
- 197.02
- Period
- 2019
- Cashfrom Operating Activities
- 3.66
- Cashfrom Investing Activities
- -0.92
- Cashfrom Financing Activities
- -2.72
- Net Changein Cash
- 0.02
- Period
- 2018
- Total Revenue
- 69.12
- Selling/ General/ Admin Expenses Total
- 2.76
- Depreciation/ Amortization
- 1.03
- Other Operating Expenses Total
- 16.26
- Total Operating Expense
- 62.11
- Operating Income
- 7.01
- Net Income Before Taxes
- 2.16
- Net Income
- 1.53
- Diluted Normalized EPS
- 4.22
- Period
- 2018
- Total Assets
- 124.19
- Total Liabilities
- 54.57
- Total Equity
- 69.62
- Tangible Book Valueper Share Common Eq
- 193
- Period
- 2018
- Cashfrom Operating Activities
- 8.84
- Cashfrom Investing Activities
- -1.31
- Cashfrom Financing Activities
- -7.55
- Net Changein Cash
- -0.02
- Period
- 2024-12-31
- Total Revenue
- 53.71
- Selling/ General/ Admin Expenses Total
- 1.27
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 8.73
- Total Operating Expense
- 46.59
- Operating Income
- 7.12
- Net Income Before Taxes
- 6.46
- Net Income
- 4.7
- Diluted Normalized EPS
- 13.03
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 39.16
- Selling/ General/ Admin Expenses Total
- 1.31
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 8.1
- Total Operating Expense
- 42.34
- Operating Income
- -3.19
- Net Income Before Taxes
- -4
- Net Income
- -2.99
- Diluted Normalized EPS
- -8.29
- Period
- 2024-09-30
- Total Assets
- 145.65
- Total Liabilities
- 64.55
- Total Equity
- 81.1
- Tangible Book Valueper Share Common Eq
- 224.8
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -5.95
- Cashfrom Investing Activities
- 2.18
- Cashfrom Financing Activities
- -1.77
- Net Changein Cash
- -5.54
- Period
- 2024-06-30
- Total Revenue
- 7.97
- Selling/ General/ Admin Expenses Total
- 1.05
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 2.67
- Total Operating Expense
- 8.04
- Operating Income
- -0.07
- Net Income Before Taxes
- -0.68
- Net Income
- -0.5
- Diluted Normalized EPS
- -1.39
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 24.62
- Selling/ General/ Admin Expenses Total
- 1.05
- Depreciation/ Amortization
- 0.22
- Other Operating Expenses Total
- 4.3
- Total Operating Expense
- 24.12
- Operating Income
- 0.5
- Net Income Before Taxes
- 0
- Net Income
- -0.33
- Diluted Normalized EPS
- -0.91
- Period
- 2024-03-31
- Total Assets
- 120.93
- Total Liabilities
- 36.34
- Total Equity
- 84.59
- Tangible Book Valueper Share Common Eq
- 234.49
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 15.64
- Cashfrom Investing Activities
- 5.68
- Cashfrom Financing Activities
- -15.76
- Net Changein Cash
- 5.55
- Period
- 2023-12-31
- Total Revenue
- 42.27
- Selling/ General/ Admin Expenses Total
- 1.1
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 7.05
- Total Operating Expense
- 38.78
- Operating Income
- 3.49
- Net Income Before Taxes
- 2.74
- Net Income
- 2.05
- Diluted Normalized EPS
- 5.68
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 37.94
- Selling/ General/ Admin Expenses Total
- 1.15
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 7.31
- Total Operating Expense
- 35.54
- Operating Income
- 2.39
- Net Income Before Taxes
- 1.47
- Net Income
- 1.11
- Diluted Normalized EPS
- 3.08
- Period
- 2023-09-30
- Total Assets
- 156.77
- Total Liabilities
- 73.66
- Total Equity
- 83.12
- Tangible Book Valueper Share Common Eq
- 230.41
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 3.61
- Cashfrom Investing Activities
- 6.75
- Cashfrom Financing Activities
- -9.68
- Net Changein Cash
- 0.67
- Period
- 2023-06-30
- Total Revenue
- 10.13
- Selling/ General/ Admin Expenses Total
- 1.04
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 2.78
- Total Operating Expense
- 10.52
- Operating Income
- -0.39
- Net Income Before Taxes
- -1.1
- Net Income
- -0.82
- Diluted Normalized EPS
- -2.28
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 35.99
- Selling/ General/ Admin Expenses Total
- 1.01
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 10.53
- Total Operating Expense
- 34.09
- Operating Income
- 1.9
- Net Income Before Taxes
- 1.04
- Net Income
- 0.67
- Diluted Normalized EPS
- 1.87
- Period
- 2023-03-31
- Total Assets
- 141.94
- Total Liabilities
- 59.11
- Total Equity
- 82.83
- Tangible Book Valueper Share Common Eq
- 229.61
- Period
- 2023-03-31
- Cashfrom Operating Activities
- -14.93
- Cashfrom Investing Activities
- -4.63
- Cashfrom Financing Activities
- 15.19
- Net Changein Cash
- -0.01
- Period
- 2022-12-31
- Total Revenue
- 60.12
- Selling/ General/ Admin Expenses Total
- 1.17
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 8.65
- Total Operating Expense
- 48.21
- Operating Income
- 11.9
- Net Income Before Taxes
- 10.68
- Net Income
- 7.93
- Diluted Normalized EPS
- 21.99
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
The Phosphate Company Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Teesta Agro Industries
- 107
- -0.85
- -0.79
- 159.98
- 75
- 60.02
- Medi Caps
- 43.48
- -0.49
- -1.11
- 61
- 41
- 54.22
- The Phosphate Company
- 146.25
- 0
- 0
- 207.9
- 134.95
- 52.76
- National Oxygen
- 104.7
- 0.55
- 0.53
- 184.9
- 102.5
- 52.79
- Yash Chemex
- 47.55
- -1.51
- -3.08
- 66.7
- 39.2
- 49.06
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Teesta Agro Industries
- 19.38
- 0.54
- 4.48
- 2.72
- Medi Caps
- -
- 0.45
- 2.8
- 6.1
- The Phosphate Company
- 26.31
- 0.62
- 3.63
- 2.75
- National Oxygen
- -
- -
- -
- 0.42
- Yash Chemex
- -
- 1.41
- 7.49
- 3.15
The Phosphate Company Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 04-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results & A.G.M.
- 29-May-24
- Audited Results
- 08-Feb-24
- Quarterly Results
- 02-Nov-23
- Quarterly Results
- 31-Jul-23
- Quarterly Results & A.G.M.
- 26-May-23
- Audited Results
- 17-May-23
- Others
- Meeting Date
- Announced on
- Purpose
- 25-Sept-24
- 27-Aug-24
- AGM
- 22-Sept-23
- 23-Aug-23
- AGM
- 12-Feb-23
- 09-Jan-23
- POM



